Preoperative localizing studies for initial parathyroidectomy in MEN1 syndrome: Is there any benefit?

World Journal of Surgery

Volumn 36, Issue 6, 2012, Pages 1368-1374

  Nilubol, Naris ^a   Weinstein, Lee ^b   Simonds, William F ^b   Jensen, Robert T ^b   Phan, Giao Q ^a   Hughes, Marybeth S ^a   Libutti, Steven K ^c   Marx, Stephen ^b   Kebebew, Electron ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHORISTOMA; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; EVALUATION; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA; NECK; NUCLEAR MAGNETIC RESONANCE IMAGING; PARATHYROID GLAND; PARATHYROID TUMOR; PARATHYROIDECTOMY; PREOPERATIVE CARE; PRIMARY HYPERPARATHYROIDISM; RADIOGRAPHY; RETROSPECTIVE STUDY; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CHORISTOMA; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; NECK; PARATHYROID GLANDS; PARATHYROID NEOPLASMS; PARATHYROIDECTOMY; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PREOPERATIVE CARE; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84864289772     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-012-1451-1     Document Type: Article

References (32)

1. Skogseid B, Eriksson B, Lundqvist G et al (1991) Multiple endocrine neoplasia type 1: a 10-year prospective screening study in four kindreds. J Clin Endocrinol Metab 73:281-287 (Pubitemid 21921870)
2. Lairmore TC, Piersall LD, DeBenedetti MK et al (2004) Clinical genetic testing and early surgical intervention in patients with multiple endocrine neoplasia type 1 (MEN 1). Ann Surg 239: 637-645 discussion 645-637
3. Marini F, Falchetti A, Luzi E et al (2009) Multiple endocrine neoplasia type 1 (MEN1) syndrome. In: Riegert-Johnson DL, Boardman LA, Hefferon T, Roberts M (eds) Cancer syndromes. National Center for Biotechnology Information, Bethesda
4. Brandi ML, Marx SJ, Aurbach GD et al (1987) Familial multiple endocrine neoplasia type I: a new look at pathophysiology. Endocr Rev 8:391-405
5. Vasen HF, Griffioen G, Lips CJ et al (1990) Screening of families predisposed to cancer development in the Netherlands. Anticancer Res 10:555-563 (Pubitemid 20175637)
6. Uchino S, Noguchi S, Sato M et al (2000) Screening of the Men1 gene and discovery of germ-line and somatic mutations in apparently sporadic parathyroid tumors. Cancer Res 60:5553-5557
7. Akerstrom G, Stalberg P (2009) Surgical management of MEN-1 and -2: state of the art. Surg Clin North Am 89:1047-1068
8. VanderWalde LH, Haigh PI (2006) Surgical approach to the patient with familial hyperparathyroidism. Curr Treat Options Oncol 7:326-333 (Pubitemid 44043662)
9. Lambert LA, Shapiro SE, Lee JE et al (2005) Surgical treatment of hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Arch Surg 140:374-382 (Pubitemid 40489957)
10. Hubbard JG, Sebag F, Maweja S et al (2002) Primary hyperparathyroidism in MEN 1 - how radical should surgery be? Langenbecks Arch Surg 386:553-557 (Pubitemid 34285634)
11. Thompson NW (1995) The surgical management of hyperparathyroidism and endocrine disease of the pancreas in the multiple endocrine neoplasia type 1 patient. J Intern Med 238:269-280
12. Powell AC, Alexander HR, Pingpank JF et al (2008) The utility of routine transcervical thymectomy for multiple endocrine neoplasia 1-related hyperparathyroidism. Surgery 144:878-883 discussion 883-874
13. Stalberg P, Carling T (2009) Familial parathyroid tumors: diagnosis and management. World J Surg 33:2234-2243. doi:10.1007/s00268-009-9924-6
14. Hellman P, Skogseid B, Oberg K et al (1998) Primary and reoperative parathyroid operations in hyperparathyroidism of multiple endocrine neoplasia type 1. Surgery 124:993-999 (Pubitemid 28555184)
15. Brandi ML, Gagel RF, Angeli A et al (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86:5658-5671 (Pubitemid 33152604)
16. Miller DL, Doppman JL, Shawker TH et al (1987) Localization of parathyroid adenomas in patients who have undergone surgery. Part I. Noninvasive imaging methods. Radiology 162:133-137 (Pubitemid 17001796)
17. Chen CC, Skarulis MC, Fraker DL et al (1995) Technetium- 99 m-sestamibi imaging before reoperation for primary hyperparathyroidism. J Nucl Med 36:2186-2191
18. Feingold DL, Alexander HR, Chen CC et al (2000) Ultrasound and sestamibi scan as the only preoperative imaging tests in reoperation for parathyroid adenomas. Surgery 128:1103-1109 discussion 1109-1110
19. Westerdahl J, Bergenfelz A (2007) Unilateral versus bilateral neck exploration for primary hyperparathyroidism: five-year follow-up of a randomized controlled trial. Ann Surg 246: 976-980 discussion 980-971 (Pubitemid 350179184)
20. Rizzoli R, Green J 3rd, Marx SJ (1985) Primary hyperparathyroidism in familial multiple endocrine neoplasia type I. Long-term follow-up of serum calcium levels after parathyroidectomy. Am J Med 78:467-474 (Pubitemid 15107930)
21. Burgess JR, David R, Parameswaran V et al (1998) The outcome of subtotal parathyroidectomy for the treatment of hyperparathyroidism in multiple endocrine neoplasia type 1. Arch Surg 133:126-129 (Pubitemid 28092908)
22. Kraimps JL, Duh QY, Demeure M et al (1992) Hyperparathyroidism in multiple endocrine neoplasia syndrome. Surgery 112:1080-1086 discussion 1086-1088
23. Prinz RA, Gamvros OI, Sellu D et al (1981) Subtotal parathyroidectomy for primary chief cell hyperplasia of the multiple endocrine neoplasia type I syndrome. Ann Surg 193:26-29 (Pubitemid 11130868)
24. Katai M, Sakurai A, Ikeo Y et al (2001) Primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1: comparison with sporadic parathyroid adenomas. Horm Metab Res 33:499-503 (Pubitemid 32881898)
25. Gomes EM, Nunes RC, Lacativa PG et al (2007) Ectopic and extranumerary parathyroid glands location in patients with hyperparathyroidism secondary to end stage renal disease. Acta Cir Bras 22:105-109 (Pubitemid 46597118)
26. Schneider R, Waldmann J, Ramaswamy A et al (2011) Frequency of ectopic and supernumerary intrathymic parathyroid glands in patients with renal hyperparathyroidism: analysis of 461 patients undergoing initial parathyroidectomy with bilateral cervical thymectomy. World J Surg 35:1260-1265. doi:10.1007/s00268-011-1079-6
27. Uno N, Tominaga Y, Matsuoka S et al (2008) Incidence of parathyroid glands located in thymus in patients with renal hyperparathyroidism. World J Surg 32:2516-2519. doi:10.1007/s00268-008-9739-x
28. Phitayakorn R, McHenry CR (2006) Incidence and location of ectopic abnormal parathyroid glands. Am J Surg 191:418-423 (Pubitemid 43266018)
29. Sofferman RA, Nathan MH (1998) The ectopic parathyroid adenoma: a cost justification for routine preoperative localization with technetium Tc 99 m sestamibi scan. Arch Otolaryngol Head Neck Surg 124:649-654 (Pubitemid 28272930)
30. Fuster D, Ybarra J, Ortin J et al (2006) Role of pre-operative imaging using 99 mTc-MIBI and neck ultrasound in patients with secondary hyperparathyroidism who are candidates for subtotal parathyroidectomy. Eur J Nucl Med Mol Imaging 33: 467-473
31. Perie S, Fessi H, Tassart M et al (2005) Usefulness of combination of high-resolution ultrasonography and dual-phase dualisotope iodine 123/technetium Tc 99 m sestamibi scintigraphy for the preoperative localization of hyperplastic parathyroid glands in renal hyperparathyroidism. Am J Kidney Dis 45:344-352 (Pubitemid 40431061)
32. Vulpio C, Bossola M, De Gaetano A et al (2010) Usefulness of the combination of ultrasonography and 99mTc-sestamibi scintigraphy in the preoperative evaluation of uremic secondary hyperparathyroidism. Head Neck 32:1226-1235